Directorate Change
Transense Technologies plc announced that Chief Financial Officer Melvyn Segal will retire in November 2026, after which he will remain as a non-executive director for one year. Richard Michael Pearce ACA has been appointed as Finance Director designate, effective September 1, 2026, and will join the Board upon Segal's departure. Pearce brings extensive financial experience, including a recent role at Lombard Medical where he contributed to revenue growth from £6 million to £25 million annually since 2018.
Select text to share a quote on X · sign in to keep highlights & notes in your TRT notes
Transense Technologies plc (AIM: TRT), the provider of specialist sensor technology and measurement solutions, announces that Melvyn Segal has informed the Board of his intention to retire from the role of Chief Financial Officer ("CFO") and Company Secretary with effect from the Company's Annual General Meeting (AGM) in November 2026. The Board also announces the appointment of Richard Michael Pearce ACA as Finance Director with effect from 1 September 2026.
Melvyn will remain with the Company in an executive capacity for a handover period until the AGM, and will subsequently remain on the Board as a non-executive director for a further year. The Board would like to thank Melvyn for his significant contribution to Transense over many years, during which the Company and its prospects have been transformed.
Richard brings over twenty years of financial, commercial and listed company experience to Transense. Since qualifying as a Chartered Accountant with Ernst & Young in 1999, he has held senior finance roles at GE Healthcare and TD Williamson, and most recently as Finance Director at Lombard Medical where he oversaw a scale-up in revenues from £6m to £25m per annum since 2018. He will initially work alongside Melvyn in a non-board role as Finance Director, with progression to the Board leading the Group's finance function when Melvyn's steps down as CFO in November 2026.
The Board welcomes Richard to his new role and we look forward to his contribution to delivery of the future growth strategy.
| Cavendish Capital Market Limited (Nominated Adviser and Broker) Adrian Hadden / Callum Davidson (Corporate Finance) Jasper Berry (Sales) | 0207 220 0500 |
| Investor Relations Anice McNamee | Tel: +44 (0)1869 238380 Investor.relations@transense.co.uk |
Find out more at: https://www.transense.com/
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.